SCHEMBL7703237

SCHEMBL7703237

Nc1cc(-c2ccc(Cl)cc2)cc(N)n1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.55
▸ DYRK1A Q13627 9/20 0.53
▸ CDK9 P50750 2/20 0.53
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ AHR P35869 1/20 0.50
▸ MKNK1 Q9BUB5 1/20 0.48
▸ MKNK2 Q9HBH9 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.45
▸ NOTUM Q6P988 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ LTA4H P09960 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ ALPL P05186 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19380933 0.81 BACE1 (0.44) BACE1DYRK1ACDK9NPC1RAB9A
SCHEMBL19356908 0.80 MCL1 (0.60) BACE1NOTUM
SCHEMBL28865740 0.79 NPC1 (0.65) BACE1NPC1RAB9AMKNK1MKNK2
SCHEMBL13551944 0.79 DYRK1A (0.48) DYRK1ACDK9MEN1KMT2A
SCHEMBL7427550 0.77 AHR (0.61) DYRK1ACDK9NPC1RAB9AAHR
SCHEMBL7708389 0.77 DYRK1A (0.50) DYRK1ACDK9ADORA2AADORA1
SCHEMBL7705913 0.76 DYRK1A (0.46) BACE1DYRK1ACDK9NPC1RAB9A
SCHEMBL7708521 0.76 MEN1 (0.67) DYRK1ACDK9NPC1RAB9AKDM4E
SCHEMBL19356913 0.76 CTRC (0.40) BACE1NPC1RAB9AKDM4ENOTUM
SCHEMBL9160072 0.76 AHR (0.68) BACE1AHRKDM4ENOTUMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 — — US disclosed
Send feedback